Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 114 of 200 Β· By data quality, then INN

  1. venlafaxine besylate

    VENLAFAXINE BESYLATE

    ORAL FDA: approved

  2. vepdegestrant

    VEPPANU

    ORAL FDA: approved

  3. veratrum viride root

    VERTAVIS

    ORAL FDA: approved

  4. vericiguat

    VERQUVO Bayer Australia Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    C01
  5. verteporfin

    VISUDYNE

    INJECTION FDA: approved Β· EMA: approved

    S01LA01
  6. vibegron

    OBGEMSA

    ORAL FDA: approved Β· EMA: approved

    G04BD15
  7. vidarabine

    VIRA-A

    OPHTHALMIC FDA: approved

  8. viltolarsen

    VILTEPSO

    INTRAVENOUS FDA: approved Β· PMDA: approved

  9. vimseltinib

    ROMVIMZA

    ORAL FDA: approved Β· EMA: approved

    L01EX
  10. vinblastine sulfate

    VINBLASTINE SULFATE

    INJECTION FDA: approved

  11. viomycin sulfate

    VIOCIN SULFATE

    INJECTION FDA: approved

  12. vismodegib

    ERIVEDGE Hoffmann-La Roche

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L01XX43
  13. vitamin a

    VITAMIN A

    ORAL FDA: approved

  14. vorapaxar sulfate

    ZONTIVITY

    ORAL FDA: approved

  15. vorasidenib

    VORANIGO

    ORAL FDA: approved Β· EMA: approved

    L01XM04
  16. vorinostat

    ZOLINZA Merck KGaA, Darmstadt, Germany

    ORAL FDA: approved Β· EMA: application withdrawn Β· TGA: approved

  17. vortioxetine

    BRINTELLIX

    ORAL FDA: approved Β· EMA: approved

    N06AX26
  18. voxelotor

    OXBRYTA

    ORAL FDA: approved Β· EMA: suspended

    B06AX03
  19. warfarin potassium

    ATHROMBIN-K

    ORAL FDA: approved

  20. xenon xe-127

    XENON XE 127

    INHALATION FDA: approved

  21. xenon xe-129 hyperpolarized

    XENOVIEW

    INHALATION FDA: approved

  22. xylose

    XYLOSE

    ORAL FDA: approved

  23. zafirlukast

    ZAFIRLUKAST

    ORAL FDA: approved

  24. zalcitabine

    HIVID

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.